Skip to main content
Quratis Inc. logo

Quratis Inc. — Investor Relations & Filings

Ticker · 348080 ISIN · KR7348080003 KO Manufacturing
Open in API
Filings indexed 238 across all filing types
Latest filing 2023-09-25 Capital/Financing Update
Country KR South Korea
Listing KO 348080

About Quratis Inc.

https://www.quratis.com

Quratis Inc. is a biopharmaceutical company specializing in the research and development of vaccines and therapeutic agents for infectious diseases. The company's lead pipeline candidate is QTP101, a novel tuberculosis (TB) vaccine developed for adolescents and adults, an area with significant unmet medical needs. Quratis operates its own GMP-certified manufacturing facility, enabling the production of various biologics such as DNA plasmids, RNA, and proteins to support its development programs. The company is advancing the global commercialization of its TB vaccine through strategic partnerships and technology transfers, with notable progress in key Asian markets.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and a subsequent correction (정정신고) for the company Quratis. This type of filing, which details capital structure changes, financing activities, and specific terms of debt instruments, falls under the 'Capital/Financing Update' category.
2023-09-25 Korean
본점소재지변경
Regulatory Filings Classification · 100% confidence The document is a short regulatory announcement regarding a change in the company's registered office address (headquarters). It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor does it relate to dividends, share transactions, or management changes. As it is a standard regulatory disclosure of corporate information, it falls under the general regulatory filing category.
2023-09-15 Korean
투자판단관련주요경영사항(임상시험계획자진취하등)(장년 및 노년을 위한 QTP101 결핵백신의 제 2a상시험으로 국내 임상시험계획(IND)승인 신청 자진 취하)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure from a Korean company (Curatis) regarding the voluntary withdrawal of a clinical trial application (IND). It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) filed with the Korea Exchange (KRX). Since this is a specific regulatory announcement regarding clinical trial status and does not fit into categories like financial reports, dividends, or board changes, it is classified as a general regulatory filing.
2023-09-12 Korean
투자판단관련주요경영사항(임상시험계획승인신청)(성인(55~74세, 장년 및 노년)을 위한 QTP101 결핵백신의 제1상 시험으로 국내 임상시험계획(IND)승인 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KIND) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically the application for approval of a clinical trial (IND) for a tuberculosis vaccine. Since this is a specific regulatory announcement regarding clinical trial status and does not fit into the other specialized categories like financial reports or shareholder meetings, it is classified as a Regulatory Filing (RNS).
2023-09-11 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed by Welcome Asset Management regarding their holdings in Curatis (주)큐라티스. This type of filing is a standard regulatory requirement in South Korea for entities that cross specific ownership thresholds in a publicly traded company. It details the number of shares held, changes in ownership (buy/sell transactions), and the purpose of the holding. This falls under the 'Major Shareholding Notification' category.
2023-08-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and special relationships of major shareholders (specifically Cho Kwan-goo and related parties) in the company 'Quratis'. This type of filing is used to notify the market of significant changes in share ownership and is classified as a Major Shareholding Notification.
2023-08-21 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.